1. Home
  2. TRNO vs ALKS Comparison

TRNO vs ALKS Comparison

Compare TRNO & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terreno Realty Corporation

TRNO

Terreno Realty Corporation

HOLD

Current Price

$65.59

Market Cap

6.8B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$54.01

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRNO
ALKS
Founded
2009
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.5B
IPO Year
2009
2012

Fundamental Metrics

Financial Performance
Metric
TRNO
ALKS
Price
$65.59
$54.01
Analyst Decision
Buy
Buy
Analyst Count
12
14
Target Price
$67.83
$43.43
AVG Volume (30 Days)
842.1K
2.4M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
3.21%
N/A
EPS Growth
103.65
N/A
EPS
0.66
N/A
Revenue
$476,383,000.00
$1,475,899,000.00
Revenue This Year
$8.42
$24.26
Revenue Next Year
$9.10
$4.47
P/E Ratio
$99.05
N/A
Revenue Growth
24.51
N/A
52 Week Low
$53.00
$25.17
52 Week High
$67.83
$53.69

Technical Indicators

Market Signals
Indicator
TRNO
ALKS
Relative Strength Index (RSI) 51.99 86.31
Support Level $63.63 $27.65
Resistance Level $67.18 N/A
Average True Range (ATR) 1.62 1.97
MACD -0.01 0.76
Stochastic Oscillator 58.06 89.37

Price Performance

Historical Comparison
TRNO
ALKS

About TRNO Terreno Realty Corporation

Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: